[TASEK] QoQ TTM Result on 31-Mar-2012 [#1]

Stock
[TASEK] TASEK CORPORATION BHD
Announcement Date
30-Apr-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Mar-2012 [#1]
Profit Trend
QoQ- 1.45%
YoY- -33.54%
Quarter Report
Latest QR
Upcoming QR
TASEK's Result
TASEK's Financial Summary
View:
Show?
TTM Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 564,540 597,999 590,589 590,432 566,185 532,623 543,409 2.56%
PBT 119,319 137,825 135,100 134,775 132,291 165,355 178,401 -23.42%
Tax -27,432 -33,252 -31,531 -30,124 -29,133 -17,631 -19,836 24.00%
NP 91,887 104,573 103,569 104,651 103,158 147,724 158,565 -30.37%
-
NP to SH 91,887 104,573 103,569 104,651 103,158 147,724 158,565 -30.37%
-
Tax Rate 22.99% 24.13% 23.34% 22.35% 22.02% 10.66% 11.12% -
Total Cost 472,653 493,426 487,020 485,781 463,027 384,899 384,844 14.61%
-
Net Worth 935,028 915,551 919,986 968,841 981,728 949,186 945,533 -0.73%
Dividend
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Div 146,022 135,692 135,692 123,959 123,959 152,474 152,474 -2.82%
Div Payout % 158.92% 129.76% 131.02% 118.45% 120.16% 103.22% 96.16% -
Equity
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Net Worth 935,028 915,551 919,986 968,841 981,728 949,186 945,533 -0.73%
NOSH 121,647 121,765 121,800 121,785 123,939 124,057 124,036 -1.28%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin 16.28% 17.49% 17.54% 17.72% 18.22% 27.74% 29.18% -
ROE 9.83% 11.42% 11.26% 10.80% 10.51% 15.56% 16.77% -
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
RPS 464.08 491.11 484.88 484.81 456.82 429.34 438.10 3.89%
EPS 75.54 85.88 85.03 85.93 83.23 119.08 127.84 -29.47%
DPS 120.00 110.00 110.00 100.00 100.00 122.91 122.93 -1.58%
NAPS 7.6864 7.519 7.5532 7.9553 7.921 7.6512 7.623 0.55%
Adjusted Per Share Value based on latest NOSH - 121,785
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
RPS 456.67 483.74 477.74 477.61 458.00 430.85 439.58 2.56%
EPS 74.33 84.59 83.78 84.65 83.45 119.50 128.27 -30.37%
DPS 118.12 109.76 109.76 100.27 100.27 123.34 123.34 -2.82%
NAPS 7.5637 7.4061 7.442 7.8372 7.9414 7.6782 7.6486 -0.73%
Price Multiplier on Financial Quarter End Date
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Date 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 -
Price 12.88 10.92 8.75 8.50 7.80 6.90 7.90 -
P/RPS 2.78 2.22 1.80 1.75 1.71 1.61 1.80 33.43%
P/EPS 17.05 12.72 10.29 9.89 9.37 5.79 6.18 96.10%
EY 5.86 7.86 9.72 10.11 10.67 17.26 16.18 -49.03%
DY 9.32 10.07 12.57 11.76 12.82 17.81 15.56 -28.83%
P/NAPS 1.68 1.45 1.16 1.07 0.98 0.90 1.04 37.47%
Price Multiplier on Announcement Date
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Date 18/02/13 25/10/12 26/07/12 30/04/12 16/02/12 28/10/11 28/07/11 -
Price 14.56 14.00 9.78 8.67 8.00 7.84 7.76 -
P/RPS 3.14 2.85 2.02 1.79 1.75 1.83 1.77 46.29%
P/EPS 19.28 16.30 11.50 10.09 9.61 6.58 6.07 115.32%
EY 5.19 6.13 8.69 9.91 10.40 15.19 16.47 -53.53%
DY 8.24 7.86 11.25 11.53 12.50 15.68 15.84 -35.19%
P/NAPS 1.89 1.86 1.29 1.09 1.01 1.02 1.02 50.57%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment